Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy (Q36625503)

15 August 2017

Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy (English)

1 reference

cardiac magnetic resonance imaging

15 August 2017

1 reference

1 reference

inferred from title

author

Michael Jerosch-Herold

object named as

Michael Jerosch-Herold

1 reference

15 August 2017

Raymond Y Kwong

1 reference

15 August 2017

Tomas G Neilan

1 reference

15 August 2017

Otavio R Coelho-Filho

1 reference

15 August 2017

Bobak Heydari

1 reference

15 August 2017

Ravi V Shah

1 reference

15 August 2017

Jiazuo H Feng

1 reference

15 August 2017

Diego Pena-Herrera

1 reference

15 August 2017

Damien Mandry

1 reference

15 August 2017

Francois Pierre-Mongeon

1 reference

15 August 2017

Sanjeev A Francis

1 reference

15 August 2017

Javid Moslehi

1 reference

15 August 2017

language of work or name

English

0 references

publication date

8 December 2012

1 reference

American Journal of Cardiology

15 August 2017

1 reference

15 August 2017

111

1 reference

15 August 2017

1 reference

15 August 2017

717-722

1 reference

Quantification of extracellular matrix expansion by CMR in infiltrative heart disease

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Pathology of late-onset anthracycline cardiomyopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578020

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

21 October 2018

1 reference

12 December 2020

Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study

1 reference

12 December 2020

Human myocardial histologic characteristics in congestive heart failure

1 reference

12 December 2020

A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin

1 reference

12 December 2020

Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

1 reference

12 December 2020

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping

1 reference

12 December 2020

10.1016/J.AMJCARD.2012.11.022

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23228924

1 reference